ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice

Zou, Jian; Yan, Chunyan*; Wan, Jian-Bo*广东药学院
Chinese Medicine2022-1-25DOI: 10.1186/s13020-022-00573-z
13被引13阅读
引用收藏
分享

摘要

Background: Red yeast rice (RYR), a nutraceutical with a profound cholesterol-lowering effect, was found to attenuate non-alcoholic fatty liver disease (NAFLD) in mice. Despite monacolin K in RYR being a specific inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMCGR), the mechanisms underlying the protective effects of RYR against NAFLD are not fully elucidated. @@@ Methods: Using a mouse model of high-fat diet (HFD) feeding and a cellular model of HepG2 cells challenged by lipopolysaccharide (LPS) and palmitic acid (PA), the possible molecular mechanisms were exploited in the aspects of NF-kappa B/NLRP3 inflammasome and mTORC1-SREBPs signaling pathways by examining the relevant gene/protein expressions. Subsequently, the correlation between these two signals was also verified using cellular experiments. @@@ Results: RYR ameliorated lipid accumulation and hepatic inflammation in vivo and in vitro. RYR improved lipid metabolism through modulating mTORC1-SREBPs and their target genes related to triglyceride and cholesterol synthesis. Furthermore, RYR suppressed hepatic inflammation by inhibiting the NF-kappa B/NLRP3 inflammasome signaling. Interestingly, the treatment with RYR or MCC950, a specific NLRP3 inhibitor, resulted in the reduced lipid accumulation in HepG2 cells challenged by LPS plus PA, suggesting that the inhibitory effects of RYR on NLRP3 inflammasome-mediated hepatic inflammation may partially, in turn, contribute to the lipid-lowering effect of RYR. @@@ Conclusions: The modulation of NF-kappa B/NLRP3 inflammasome and lipid synthesis may contribute to the ameliorative effects of RYR against HFD-induced NAFLD.

学科与关键词

关键词
NAFLDNF-kappa BNLRP3 inflammasomeRed yeast riceLipid synthesis
相关
加载中…
  • NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
    Wang, Xianfei; Sun, Kangyue; Zhou, Youlian; Wang, Hong; Zhou, Yongjian; Liu, Side; Nie, Yuqiang*; Li, Yue*Biochemical and Biophysical Research Communications, 2021, 534: 734-739.被引 28
  • Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*International Immunopharmacology, 2022, 111: 109099.被引 9
  • Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-ΚB/NLRP3 signaling pathway
    Deng, Yan-fang; Xu, Qian-qian; Chen, Tian-qi; Ming, Jia-xiong; Wang, Ya-fen; Mao, Li-na; Zhou, Jia-jun; Sun, Wei-guang*; Zhou, Qun*; Ren, Hong*; Zhang, Yong-hui*PHYTOMEDICINE, 2022, 104: 154241.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Chinese Medicine
发表日期
2022-01-25
卷期
第 17 卷, 第 1 期
页码
17
DOI
10.1186/s13020-022-00573-z
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Enterprise Cooperation Project [CP/003/2018]; Science and Technology Development Fund, Macau SAR [0034/2019/A1]

作者

  • Z

    Zou, Jian (第一作者)

  • Y

    Yan, Chunyan (通讯)

    guangdong pharmaceut univ

查看全部 3 位作者收起作者
  • W

    Wan, Jian-Bo (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417